Seoul National University Hospital

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 2003-01-01

Employees: 501

Market Cap: -

Website: https://www.snubh.org

Clinical Trials

A Study of Sunitinib in Patients With Metastatic or Recurrent Thymic Carcinoma

Phase 2

Completed

Conditions: Thymic Carcinoma

Interventions: Drug: Sunitinib

First Posted Date: 2015-12-07

Last Posted Date: 2019-01-23

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 25

Registration Number: NCT02623127

Locations: 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Korea, Republic of

Treatment Shortening of MDR-TB Using Existing and New Drugs

Phase 2

Completed

Conditions: Tuberculosis, Multidrug-Resistant

Interventions: Drug: Locally-used WHO-approved MDR-TB regimen in Korea
Drug: Linezolid
Drug: Delamanid
Drug: Levofloxacin
Drug: Pyrazinamide

First Posted Date: 2015-12-02

Last Posted Date: 2025-01-03

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 214

Registration Number: NCT02619994

Locations: 🇰🇷
Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine, Seoul, Korea, Republic of

Concurrent Oxytocin With Membrane Sweeping Versus Dinoprostone Pessary in Labor Induction of Multiparous Women at Term

Not Applicable

Completed

Conditions: Failed Induction of Labor

Interventions: Drug: Oxytocin
Procedure: Membrane sweeping
Drug: Dinoprostone

First Posted Date: 2015-12-01

Last Posted Date: 2020-03-04

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 154

Registration Number: NCT02618096

Locations: 🇰🇷
Department of Obstetrics and Gynecology Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of

Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia

Phase 4

Conditions: Mycoplasma Pneumoniae Pneumonia

Interventions: Drug: Levofloxacin
Drug: Prednisolone

First Posted Date: 2015-12-01

Last Posted Date: 2018-04-27

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 80

Registration Number: NCT02618057

Locations: 🇰🇷
Seoul National University Children's Hospital, Seoul, Korea, Republic of

Objective Diagnosis Method and Efficacy of Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus

Not Applicable

Conditions: Tinnitus

Interventions: Device: Active rTMS(B)
Device: Active rTMS(A)
Device: Sham condition(C)

First Posted Date: 2015-12-01

Last Posted Date: 2018-10-09

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 80

Registration Number: NCT02617953

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

Clinical Evaluation of Efficacy and Stability of AT TORBI 709M 4-haptic Toric IOL in Cataract Surgery

Not Applicable

Conditions: Iol
Astigmatism

Interventions: Procedure: AT TORBI 709M

First Posted Date: 2015-12-01

Last Posted Date: 2015-12-01

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 20

Registration Number: NCT02618018

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

Initial Combination of Gemigliptin and Metformin on Microbiota Change

Not Applicable

Completed

Conditions: Diabetes

Interventions: Drug: gemigliptin/metformin
Drug: glimepiride/metformin

First Posted Date: 2015-11-20

Last Posted Date: 2021-11-22

Lead Sponsor: Seoul National University Bundang Hospital

Target Recruit Count: 70

Registration Number: NCT02609815

Locations: 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea, Republic of

Effect of Dapagliflozin on Vascular Functions in Patients With Type 2 Diabetes Compared to Gliclazide

Phase 4

Completed

Conditions: Diabetes

Interventions: Drug: Dapagliflozin
Drug: Gliclazide

First Posted Date: 2015-11-20

Last Posted Date: 2018-09-11

Lead Sponsor: Seoul National University Bundang Hospital

Target Recruit Count: 32

Registration Number: NCT02610088

Locations: 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea, Republic of

Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Coronary Artery Disease

Phase 4

Completed

Conditions: Coronary Artery Disease

Interventions: Drug: Sarpogrelate
Drug: Aspirin

First Posted Date: 2015-11-18

Last Posted Date: 2016-05-03

Lead Sponsor: Seoul National University Bundang Hospital

Target Recruit Count: 40

Registration Number: NCT02607436

Locations: 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea, Republic of

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial

Phase 4

Completed

Conditions: Non-ST Segment Elevation Myocardial Infarction
Stable Angina
Unstable Angina

Interventions: Drug: 3-months DAPT
Drug: 1-year DAPT

First Posted Date: 2015-11-10

Last Posted Date: 2023-01-10

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 2173

Registration Number: NCT02601157

Locations: 🇰🇷
Gwangju Christian Hospital, Gwangju, Korea, Republic of
🇰🇷
Chonnam National University Hospital, Gwangju, Korea, Republic of
🇰🇷
Ewha Womans University Medical Center Mokdong Hospital, Seoul, Korea, Republic of

and more 9 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy